Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 4/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 5/20 | 0.42 |
| ▸ | CNR2 | P34972 | 5/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10926348 | 0.99 | CNR1 (0.43) | LTA4HCYP4F2CYP4A11CNR1CNR2 | |
| SCHEMBL11149449 | 0.87 | ESR2 (0.44) | LTA4HCYP4F2CYP4A11PTPN1 | |
| SCHEMBL10919678 | 0.86 | ESR2 (0.43) | LTA4HCYP4F2CYP4A11PTPN1F2RL3 | |
| SCHEMBL200763 | 0.84 | TDP1 (0.46) | LTA4HCYP4F2CYP4A11 | |
| SCHEMBL6027074 | 0.84 | HTR1A (0.43) | LTA4H | |
| SCHEMBL12610480 | 0.84 | CNR1 (0.47) | CYP4F2CYP4A11CNR1CNR2CA12 | |
| SCHEMBL10918453 | 0.83 | LTA4H (0.51) | LTA4H | |
| Velaresol SCHEMBL61907 | 0.82 | PPARA (0.44) | CNR1CNR2 | |
| SCHEMBL6026753 | 0.82 | LMNA (0.42) | CNR1CNR2PTPN1 | |
| SCHEMBL11382179 | 0.82 | GAA (0.51) | CNR1CNR2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7074770-B1 | Method of DNA vaccination | SMITHKLINE BEECHAM CORPORATION (US) | 2006-07-11 | — | — | US | claimed |
| CN-1326358-A | Method of DNA vaccination | GLAXO GROUP LTD (GB) | 2001-12-12 | — | — | CN | claimed |
| EP-1107785-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2001-06-20 | — | — | EP | claimed |
| WO-2000012121-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2000-03-09 | — | — | WO | claimed |
| US-4410537-A | 3-HYDROXY-2-FORMYLPHENOXYPENTANOIC ACID DERIVATIVES | BURROUGHTS WELLCOME CO. (US) | 1983-10-18 | — | — | US | claimed |
| CN-110872228-A | Compound of substituted phenol ether and intermediate and preparation method thereof | 湖北普星特化学试剂有限公司 | 2020-03-10 | — | — | CN | disclosed |
| US-7074770-B1 | Method of DNA vaccination | SMITHKLINE BEECHAM CORPORATION (US) | 2006-07-11 | — | — | US | disclosed |
| CN-1326358-A | Method of DNA vaccination | GLAXO GROUP LTD (GB) | 2001-12-12 | — | — | CN | disclosed |
| EP-1107785-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2001-06-20 | — | — | EP | disclosed |
| WO-2000012121-A1 | METHOD OF DNA VACCINATION | GLAXO GROUP LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |
| EP-0614357-A1 | IMMUNOPOTENTIATORY AGENTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-09-14 | — | — | EP | disclosed |
| WO-1994007479-A2 | IMMUNOPOTENTIATORY AGENTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-04-14 | — | — | WO | disclosed |
| US-4410537-A | 3-HYDROXY-2-FORMYLPHENOXYPENTANOIC ACID DERIVATIVES | BURROUGHTS WELLCOME CO. (US) | 1983-10-18 | — | — | US | disclosed |
| EP-0022229-B1 | SUBSTITUTED PHENOL ETHERS, THEIR PREPARATION, INTERMEDIATES THEREFOR, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE PREPARATION THEREOF | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-12-08 | — | — | EP | disclosed |
| EP-0022229-A1 | Substituted phenol ethers, their preparation, intermediates therefor, pharmaceutical compositions containing them and the preparation thereof | THE WELLCOME FOUNDATION LIMITED (GB) | 1981-01-14 | — | — | EP | disclosed |